MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer
NCT00275210
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2246
Enrollment
INDUSTRY
Sponsor class
Conditions
Colonic Neoplasms
Interventions
DRUG:
Oxaliplatin (SR96669)
Sponsor
Sanofi